Keros Therapeutics, Inc. Company Information
Keros Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Keros Therapeutics, Inc.
- Ticker: KROS
- Exchange: NasdaqGM
- Founded: 2015
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$2.172b
- Shares Outstanding: 40.51m
- Website: https://www.kerostx.com
Number of Employees
Location
- Keros Therapeutics, Inc.
- 1050 Waltham Street
- Suite 302
- Lexington
- Massachusetts
- 02421
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| KROS | NasdaqGM (Nasdaq Global Market) | Yes | Common Stock | US | USD | Apr 2020 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/20 17:29 |
| End of Day Share Price | 2024/11/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.